COVID-19 Pneumonia
📧 Sign up to get email alerts when something new happens for COVID-19 Pneumonia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-08-07Clinical Trial Update: NAC for Attenuation of COVID-19 Symptomatology [Phase 2]
A Phase 2 clinical trial is updating on N-acetylcysteine (NAC) for attenuation of COVID-19 symptomatology, with various COVID-19-related res…
-
CLINICAL_TRIALS trial_result · 2023-07-10Clinical Trial Update: Safety, Tolerability and Efficacy of Uproleselan (GMI-1271) in Patients With COVID-19 Pneumonia [Phase 1, Phase 2]
Clinical trial update on safety, tolerability, and efficacy of Uproleselan (GMI-1271) in COVID-19 pneumonia, terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2023-06-27Clinical Trial Update: Bevacizumab in Patients With Severe Covid-19 [Phase 3]
Phase 3 clinical trial evaluating bevacizumab for patients with severe COVID-19 pneumonia; status is currently UNKNOWN.
-
CLINICAL_TRIALS research · 2023-06-18Clinical Trial Update: Immuno-bridging Study of Inactivated SARS-CoV-2 Vaccine in Healthy Population Aged 3-17 vs Aged 18 Years Old and Above [Phase 3]
Phase 3 immunobridging trial of an inactivated SARS-CoV-2 vaccine in healthy individuals aged 3–17 compared with 18 and older has completed.
-
CLINICAL_TRIALS trial_result · 2023-06-05Clinical Trial Update: Randomized, Controlled Study of IFX-1 in Patients With Severe COVID-19 Pneumonia [Phase 2, Phase 3]
A randomized, controlled study of IFX-1 (vilobelimab) in patients with severe COVID-19 pneumonia completed Phase 2/3 with results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-05-10Clinical Trial Update: GM-CSF Inhalation to Prevent ARDS in COVID-19 Pneumonia [Phase 2]
Phase 2 clinical trial assessing inhaled GM-CSF to prevent ARDS in patients with COVID-19 pneumonia has completed.
-
CLINICAL_TRIALS trial_result · 2023-04-21Clinical Trial Update: Trial of Open Label Dipyridamole- In Hospitalized Patients With COVID-19 [Phase 2]
Phase 2 open-label trial of dipyridamole in hospitalized COVID-19 patients (terminated; results posted).
-
CLINICAL_TRIALS trial_result · 2023-04-20Clinical Trial Update: Evaluation of the Efficacy and Safety of Nano-S1 [Phase 3]
Phase 3 clinical trial evaluating the efficacy and safety of Nano-S1 for COVID-19 pneumonia has completed.
-
CLINICAL_TRIALS trial_result · 2023-03-24Clinical Trial Update: Tocilizumab in COVID-19 Pneumonia (TOCIVID-19) [Phase 2]
A Phase 2 clinical trial update for tocilizumab in COVID-19 pneumonia (TOCIVID-19) with unknown current status.
-
CLINICAL_TRIALS trial_result · 2023-03-21Clinical Trial Update: Phase 2b/3 Trial of NuSepin® in COVID-19 Pneumonia Patients [Phase 2, Phase 3]
Phase 2b/3 trial update for NuSepin® in COVID-19 pneumonia is ongoing with unspecified status.
-
CLINICAL_TRIALS trial_result · 2023-02-23Clinical Trial Update: Usefulness of DORNASE in COVID-19 on HFNO [Phase 4]
Phase 4 clinical trial update evaluating the usefulness of DORNASE in COVID-19 pneumonia on high-flow nasal oxygen; the study has been termi…
-
CLINICAL_TRIALS trial_result · 2023-01-31Clinical Trial Update: Phase 2/Phase 3 Study To Evaluate The Efficacy And Safety Of Ramatroban Along With The Standard Of Care In Subjects Hospitalized For COVID Pneumonia [Phase 2, Phase 3]
A Phase 2/Phase 3 clinical trial is investigating ramatroban in addition to standard of care for hospitalized COVID-19 pneumonia patients; t…
-
CLINICAL_TRIALS trial_result · 2023-01-25Clinical Trial Update: Low-Dose Radiation Therapy for Severe COVID-19 Pneumonia [Phase 2]
Phase 2 clinical trial investigating low-dose radiation therapy for severe COVID-19 pneumonia.
-
CLINICAL_TRIALS trial_result · 2023-01-23Clinical Trial Update: Efficacy of Megadose Vitamin C in Severe and Critical Ill COVID-19 Patients. [Phase 2, Phase 3]
A clinical trial update assessing the efficacy of megadose vitamin C in severe and critical COVID-19 patients (Phase 2/Phase 3). No results …
-
CLINICAL_TRIALS trial_result · 2023-01-18Clinical Trial Update: UC-MSCs in the Treatment of Severe and Critical COVID-19 Patients With Refractory Hypoxia [Phase 3]
Phase 3 trial exploring UC-MSCs for severe and critical COVID-19 with refractory hypoxia; status is unknown.
-
CLINICAL_TRIALS trial_result · 2023-01-17Clinical Trial Update: Efficacy and Safety of Jaktinib in Patients With COVID-19 Pneumonia. [Phase 2]
Phase 2 trial update on the efficacy and safety of Jaktinib in patients with COVID-19 pneumonia.
-
CLINICAL_TRIALS trial_result · 2023-01-12Clinical Trial Update: UC-MSCs in the Treatment of Severe and Critical COVID-19 Patients [Phase 3]
Phase 3 clinical trial exploring UC-MSCs for severe and critical COVID-19 patients; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2023-01-10Clinical Trial Update: Study to Evaluate the Efficacy and Safety of AstroStem-V in Treatment of COVID-19 Pneumonia [Phase 1, Phase 2]
A clinical trial update for AstroStem-V in COVID-19 pneumonia across Phase 1 and Phase 2, status currently unknown.
-
CLINICAL_TRIALS trial_result · 2022-10-28Clinical Trial Update: NestaCell® Mesenchymal Stem Cell to Treat Patients With Severe COVID-19 Pneumonia [Phase 2]
Phase 2 clinical trial update evaluating NestaCell mesenchymal stem cells for severe COVID-19 pneumonia has completed.
-
CLINICAL_TRIALS trial_result · 2022-09-19Clinical Trial Update: Kesuting Syrup in the Treatment of Corona Virus Disease 2019 (COVID-19) [Phase 4]
Phase 4 clinical trial update on Kesuting Syrup for COVID-19 pneumonia and cough has completed.
-
CLINICAL_TRIALS trial_result · 2022-09-08Clinical Trial Update: ANTIcoagulation in Severe COVID-19 Patients [Phase 2]
Phase 2 trial update on anticoagulation in patients with severe COVID-19 pneumonia; status completed.
-
CLINICAL_TRIALS trial_result · 2022-08-03Clinical Trial Update: Investigating the Efficacy and Safety ICATIBANT For The Treatment of Patients With SARS-CoV-2 (COVID-19) Infection [Phase 2]
Phase 2 clinical trial investigating icatibant for COVID-19 pneumonia has completed.
-
CLINICAL_TRIALS trial_result · 2022-07-19Clinical Trial Update: Convalescent Plasma as Potential Therapy for Severe COVID-19 Pneumonia [Phase 3]
Clinical trial update on convalescent plasma for severe COVID-19 pneumonia, completed Phase 3 study.
-
CLINICAL_TRIALS trial_result · 2022-07-19Clinical Trial Update: Defibrotide in COVID-19 Pneumonia [Phase 2]
Phase 2 trial evaluating defibrotide in patients with COVID-19 pneumonia completed.
-
CLINICAL_TRIALS trial_result · 2022-07-08Clinical Trial Update: Study to Verify the Effectiveness and Safety of Isothymol or Carvacrol Compound Against SARS-CoV-2 in COVID-19 Patients [Phase 2, Phase 3]
A completed phase 2/3 trial investigating the effectiveness and safety of an isothymol or carvacrol compound for COVID-19 patients.